Table 2.
Sociodemographic and clinical characteristics of patients with CL
| Characteristics | TF cases | PC cases | p value (< 0.05) | |||
|---|---|---|---|---|---|---|
| n = 41 | % | n = 87 | % | |||
| Sociodemographic | ||||||
| Age (mean, IQR) | 23 (21–27) | - | 23 (21–25) | - | 0.3358 § | |
| Region where the infection was acquired | 0.020 χ* | |||||
| Caribbean | 5 | 12.2 | 1 | 1.1 | ||
| Andean | 6 | 14.6 | 11 | 12.6 | ||
| Orinoquia | 4 | 9.8 | 8 | 9.2 | ||
| Pacific | 6 | 14.6 | 30 | 34.5 | ||
| Amazon | 19 | 46.3 | 33 | 37.9 | ||
| ND | 1 | 2.4 | 4 | 4.6 | ||
| Length of stay in the region where the infection was acquired (IQR) |
5 (6-3.75) - Months |
4.5 (6 − 3) months |
- | 0.2179 § | ||
| Prevention measures | ||||||
| Netting | 33 | 80.5 | 65 | 74.7 | 0.070 χ | |
| Repellent | 25 | 61.0 | 55 | 63.2 | 0.774 χ | |
| History of leishmaniasis | ||||||
| Previous infections | 0.001 § ** | |||||
| 0 | 11 | 26.8 | 66 | 75.9 | ||
| 1 | 11 | 26.8 | 7 | 8.0 | ||
| 2 | 4 | 9.8 | 0 | 0 | ||
| 3 | 1 | 2.4 | 0 | 1.1 | ||
| 4 | 1 | 2.4 | 1 | 1.1 | ||
| ND | 13 | 31.7 | 12 | 13.8 | ||
| Previous treatment with meglumine antimoniate | 19 | 46.3 | 11 | 12.6 | 0.000χ*** | |
| Associated clinic | ||||||
| Lymphadenopathy | 9 | 22.0 | 9 | 10.3 | 0.008 § ** | |
| Number of lesions | 0.709 χ | |||||
| 1 | 36 | 81.8 | 68 | 76.4 | ||
| 2 | 4 | 9.0 | 16 | 36.3 | ||
| 3 | 2 | 4.5 | 3 | 6.8 | ||
| 4 | 1 | 2.2 | 1 | 2.2 | ||
| 5 | 1 | 2.2 | 1 | 2.2 | ||
| Location of the lesions | 0.664 χ | |||||
| Upper limb | 23 | 56.1 | 51 | 58.6 | ||
| Lower limb | 7 | 17.1 | 10 | 11.5 | ||
| Trunk or back | 3 | 7.3 | 3 | 3.4 | ||
| Face, ear, or neck | 7 | 17.1 | 17 | 19.5 | ||
| ND | 1 | 2.4 | 6 | 6.9 | ||
| Lesion type | 0.002 χ ** | |||||
| Ulcer | 31 | 75.6 | 86 | 98.9 | ||
| Papule | 3 | 7.3 | 0 | 0 | ||
| Plaque | 2 | 4.9 | 0 | 0 | ||
| Warty | 1 | 2.4 | 0 | 0 | ||
| ND | 4 | 9.8 | 1 | 1.1 | ||
| Lesion size (mean IQR) | 2.7(9 − 1) cm 2 | 1.74 (4 − 0,8) cm 2 | 0.0180 § | |||
Age: expressed in years, ND: not data
§ Wilcoxon rank-sum (Mann-Whitney)
χ Chi-square test
** -*** highly significant